Published in Gut on May 09, 2008
Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59
Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc (2013) 2.07
Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ (2009) 1.72
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
The laparoscopic Nissen-Hill hybrid: pilot study of a combined antireflux procedure. Surg Endosc (2013) 0.90
Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project. Dig Dis Sci (2011) 0.84
Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study. World J Surg (2015) 0.83
Gastroesophageal reflux disease. J Gastroenterol (2010) 0.82
What causes treatment failure - the patient, primary care, secondary care or inadequate interaction in the health services? BMC Health Serv Res (2011) 0.82
Management of the patient with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol (2013) 0.82
Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clin Epidemiol (2013) 0.78
Predicting patient dissatisfaction following laparoscopic Nissen fundoplication: an analysis of symptoms. Surg Endosc (2012) 0.77
Hiatal hernia, Barrett's esophagus, and long-term symptom control after laparoscopic fundoplication for gastroesophageal reflux. Surg Endosc (2012) 0.77
Antireflux surgery: efficacy, side effects, and other issues. Gastroenterol Hepatol (N Y) (2011) 0.76
The influence on outcome of indications for antireflux surgery. World J Surg (2010) 0.75
The cure(s) of LOTUS. Gastroenterology (2008) 0.75
Reflux symptoms and side effects among patients with gastroesophageal reflux disease at baseline, during treatment with PPIs, and after Nissen fundoplication. World J Surg (2013) 0.75
Medication-associated gastrointestinal tract injury. Virchows Arch (2017) 0.75
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA (2001) 8.40
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med (1992) 3.50
[A simple operation for control of reflux esophagitis]. Schweiz Med Wochenschr (1956) 2.78
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg (2007) 2.66
Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg (2005) 2.42
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg (2003) 2.03
Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg (1996) 1.99
Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report. Surg Endosc (1994) 1.91
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology (2004) 1.82
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol (2003) 1.80
Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol (2006) 1.75
Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol (1993) 1.75
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Aliment Pharmacol Ther (2005) 1.70
Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc (1997) 1.64
Evidence-based appraisal of antireflux fundoplication. Ann Surg (2004) 1.59
Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med (2003) 1.57
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol (2004) 1.36
Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci (2003) 1.34
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Aliment Pharmacol Ther (2006) 1.09
Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol (2006) 1.02
Surgical experience improves the long-term results of Nissen fundoplication. Scand J Gastroenterol (1999) 0.98
Nissen fundoplication: the unhappy 15%. J R Coll Surg Edinb (1986) 0.94
Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience. World J Surg (2008) 0.94
Complications of open and laparoscopic antireflux surgery: 32-year audit at a teaching hospital. J Am Coll Surg (1997) 0.88
Antireflux surgery for non-erosive and erosive reflux disease in community practice. Aliment Pharmacol Ther (2006) 0.87
Long-term results of antireflux surgery indicate the need for a randomized clinical trial. Br J Surg (2002) 0.84
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46
Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. Endoscopy (2011) 3.20
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79
Use of hospital beds: a cohort study of admissions to a provincial teaching hospital. BMJ (1988) 2.64
Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology (1997) 2.47
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
Vacuum Rabi splitting with a single quantum dot in a photonic crystal nanocavity. Nature (2004) 2.28
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Endoscopy (2011) 2.16
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Open laparoscopy: the way forward. Br J Obstet Gynaecol (1999) 2.05
[Strategies for monitoring patients with Barrett's esophagus--pro]. Dtsch Med Wochenschr (2007) 2.04
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol (1997) 2.02
Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy (2007) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology (1998) 1.92
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Computed virtual chromoendoscopy: a new tool for enhancing tissue surface structures. Endoscopy (2007) 1.81
Benefits and risks of needle-knife papillotomy. Gastrointest Endosc (1997) 1.80
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther (1999) 1.80
Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP-Plus Study). Endoscopy (2007) 1.79
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Palliative treatment of malignant esophagorespiratory fistulas with Gianturco-Z stents. A prospective clinical trial and review of the literature on covered metal stents. Am J Gastroenterol (1998) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut (2001) 1.70
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol (2002) 1.66
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Duodenal ulcer relapse after eradication of Helicobacter pylori. Lancet (1991) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Human submucosal neurones regulate intestinal epithelial cell proliferation: evidence from a novel co-culture model. Neurogastroenterol Motil (2003) 1.61
Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy (2002) 1.59
Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy (2004) 1.58
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol (2001) 1.57
Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther (2005) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53
Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus. Dig Liver Dis (2006) 1.53
Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Push-and-pull enteroscopy using the double-balloon technique: method of assessing depth of insertion and training of the enteroscopy technique using the Erlangen Endo-Trainer. Endoscopy (2005) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Antenatal screening for diabetes mellitus. Br J Obstet Gynaecol (1984) 1.47
Argon plasma coagulation for flexible endoscopic Zenker's diverticulotomy. Endoscopy (2007) 1.46
Correlation of polypoid lesions in the distal colorectum and proximal colon in asymptomatic screening subjects. Eur J Gastroenterol Hepatol (1996) 1.45
Four-Step endoscopic esophageal mucosal resection (EEMR) tube method of resection for early esophageal cancer. Endoscopy (2004) 1.44
A new self-expanding nitinol stent (JoStent SelfX) for palliation of malignant biliary obstruction: a pilot study. Endoscopy (2004) 1.44
Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut (2002) 1.43
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.41
Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralized facility testing. Eur J Gastroenterol Hepatol (2000) 1.41
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy (2012) 1.41
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol (1997) 1.40
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
Double-balloon enteroscopy: preliminary experience in patients with obscure gastrointestinal bleeding or chronic abdominal pain. Endoscopy (2003) 1.38
[Who needs a gastroenterology pathologist?]. Pathologica (1996) 1.38
Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc (1999) 1.37
Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med (1984) 1.36
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Fetal heart rate monitoring during labour--too frequent intervention, too little benefit? Lancet (1987) 1.36
Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus. Endoscopy (2007) 1.35
Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial. Gut (2008) 1.34
Pathological lesions in colonic biopsies during Parkinson's disease. Gut (2008) 1.29
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol (2001) 1.28
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc (1999) 1.28
Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol (1979) 1.28
Endoscopic closure of postoperative esophageal leaks with a novel over-the-scope clip system. Endoscopy (2010) 1.27
Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol (1984) 1.26
Lymphocytic gastritis: a positive relationship with celiac disease. J Pediatr (1994) 1.24
Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut (2007) 1.22
Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy (2002) 1.20
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy (1999) 1.18
New index for evaluation of oral glucose tolerance test results. Br Med J (1973) 1.17
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology (1991) 1.17
Observations on blood glucose and insulin determinations. Br Med J (1972) 1.16
Interphotoreceptor retinoid-binding protein and alpha-tocopherol preserve the isomeric and oxidation state of retinol. Photochem Photobiol (1992) 1.15
Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol (1996) 1.15
Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14
Computed image modification for enhancement of small-bowel surface structures at video capsule endoscopy. Endoscopy (2010) 1.14